Last reviewed · How we verify
NCT03353363
Wound Infiltration of Liposomal Bupivacaine v Plain Bupivacaine for Post-Op Pain Control in Elective Cesarean Delivery
Phase 4 trial testing Bupivacaine in Bupivacaine in 132 participants. Status unknown.
18 October 2018
Quick facts
| Lead sponsor | Brooke Army Medical Center |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 132 |
| Start date | 18 October 2017 |
| Primary completion | 18 October 2018 |
| Estimated completion | 18 February 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Bupivacaine (BUPIVACAINE) — full drug profile →
- Liposomal bupivacaine — full drug profile →
- Placebos — full drug profile →
Conditions studied
- Bupivacaine — all drugs for Bupivacaine →
- Pain, Postoperative — all drugs for Pain, Postoperative →
Sponsor
Brooke Army Medical Center
Who can join
18 and older, female only, with Bupivacaine or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized double blind placebo controlled trial to compare the post-operative pain control advantages of post-incisional wound infiltration with liposomal bupivacaine to plain bupivacaine in patients presenting for elective caesarean delivery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03353363
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bupivacaine
Trials testing the same drug.
- NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
- NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip · Phase 3 · recruiting
- NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
- NCT07430085 — Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA · Phase 4 · not yet recruiting
- NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study · Phase 4 · not yet recruiting
Other recruiting trials for Bupivacaine
Currently open trials in the same condition.
- NCT07386327 — Impact of Bupivacaine Dilution With Dextrose or Saline on Infraclavicular Block Outcomes · NA · recruiting
- NCT07276867 — Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia f · NA · recruiting
- NCT06993922 — Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management · NA · recruiting
- NCT07522736 — Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery · NA · recruiting
- NCT05824338 — Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery · EARLY_PHASE1 · recruiting
Other Brooke Army Medical Center trials
Trials by the same sponsor.
- NCT06940986 — The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System · NA · not yet recruiting
- NCT06699901 — Antibiotic Concentrations After MassivE Transfusion Study · recruiting
- NCT06602375 — The Effect of Manual Physical Therapy and Exercise in Addition to Routine Dental Care in Individuals With Temporomandibu · NA · recruiting
- NCT06560190 — Orthopaedic Manual Physical Therapy as Part of the Postpartum Care Continuum · NA · recruiting
- NCT06369701 — Effects Compressive Tissue Flossing on Lateral Elbow Tendinopathy in US Service Members · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03353363 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brooke Army Medical Center
- Last refreshed: 18 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03353363.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing